wst william j federici insider trades for west pharmaceutical services inc bulletin investor alert tokyo markets close in currencies europe markets london markets expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close west pharmaceutical services inc nyse wst go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus west pharmaceutical services inc after hours  quotes are delayed by  min jul    pm wst quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual william j federici mr william j federici is chief financial officer  senior vice president at west pharmaceutical services inc he is on the board of directors at zynerba pharmaceuticals inc and cancer care inc mr federici was previously employed as independent director by nupathe inc national industry directorpharmaceuticals by kpmg llp and audit partner by arthur andersen llp he also served on the board at synvista therapeutics inc he received his undergraduate degree from livingstone college an undergraduate degree from rutgers university new jersey and an mba from rutgers university new jersey transactions date shares transaction value     disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      award at  per share      gift at  per share      gift at  per share      gift at  per share      award at  per share      disposition at  per share      derivativenonderivative trans at  per share      gift at  per share      award at  per share      award at  per share      gift at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      gift at  per share      award at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      gift at  per share      award at  per share      derivativenonderivative trans at  per share      gift at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr patrick j zenner nonexecutive chairman mr eric mark green president chief executive officer  director mr david a montecalvo svpglobal operations  supply chain mr william j federici chief financial officer  senior vice president mr eric resnick chief technology officer  vice president mr patrick a sim chief information officer  vice president mr donald a mcmillan vice presidententerprise business systems mr chris ryan vice president  general managerglobal generics mr mike schaefers vice presidentproduct management dr scott young vice presidentprimary container technology mr graham s reynolds vice president  general managerglobal biologics mr mike treadaway vp  general managercontract manufacturing ms karen a flynn chief commercial officer  senior vice president mr heino lennartz vice president  general managerglobal pharma mr paolo pucci director ms erin o’brien senior directormarketing mr daniel malone vice president  controller dr quintin john lai vice presidentcorporate development  strategy ms emily y denney headglobal communications ms annette f favorite chief human resources officer  senior vp mr george lloyd miller secretary senior vice president  general counsel ms deborah l keller independent director mr john h weiland independent director dr myla p laigoldman independent director dr william f feehery independent director mr douglas a michels independent director mr mark a buthman independent director dr paula a johnson independent director mr thomas w hofmann independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo open marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pif you suddenly quit your job like sean spicer here’s what you should do next pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders pbanks have raised creditcard interest rates — but not savings account rates aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  nupathe inc appoints william j federici to its board of directors employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       nupathe inc appoints william j federici to its board of directors tweet   am conshohocken pamarketwire  january    nupathe inc nasdaq path a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system including neurological and psychiatric disorders today announced that william j federici vice president and chief financial officer of west pharmaceutical services inc has been appointed to the nupathe board of directors mr federici will also serve on the audit committee we are delighted to add bill to our board of directors said jane hollingsworth chief executive officer of nupathe in addition to his significant financial and accounting acumen bills experience as a chief financial officer of a global manufacturer of components and delivery systems for the pharmaceuticals healthcare and consumer products industries will be invaluable to the company especially as we prepare for a robust commercial launch of zelrix mr federici joined west pharmaceutical services in  with more than  years experience in public accounting for the pharmaceutical industry prior to joining west mr federici served as practice leader for the pharmaceuticals industry in the americas and engagement partner for several pharmaceutical companies at kpmg llp mr federici holds a ba in economics and an mba in professional accounting from rutgers university and is a certified public accountant mr federici is also an advisory board member of the rutgers university school of business and a member of the board of trustees at cancer care of new jersey about nupathe nupathe inc wwwnupathecom is a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system including neurological and psychiatric disorders nupathes most advanced product candidate zelrix is a singleuse transdermal sumatriptan patch being developed for the treatment of acute migraine in addition to zelrix nupathe has two proprietary product candidates in preclinical development np for the continuous symptomatic treatment of parkinsons disease and np for the longterm treatment of schizophrenia and bipolar disorder investor contactsjohn woolford email contactkeith a goldanvice president chief financial officernupathe inc  media contactsron schmidnupathe inc  read at biospacecom related news nupathe inc submits zelrix nda for the treatment of migraine karyopharm therapeutics inc appoints michael kauffman md phd as chief executive officer nupathe inc announces positive topline results from  month safety trial for zelrixtm alexander r wessels new president and chief executive officer of dsm pharmaceutical products nupathe inc announces successful completion of three key trials for zelrixtm mike romanos appointed as ceo of crescendo biologics nupathe inc announces third quarter  financial results and recent operational highlights savient pharmaceuticals inc svnt starts search for new ceo more than two years after last chief left nupathe inc to report third quarter  results and hold conference call on thursday november   medtronic inc mdt announces chairman and ceo william a hawkins to retire at end of company’s current fiscal year please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • nupathe inc   • biotechpharma  personnel                 william federici west pharmaceutical services inc profile  biography  bloomberg feedback william bill federici senior vpcfotreasurer west pharmaceutical services inc career history senior vpcfotreasurer west pharmaceutical services inc present natl industry director kpmg intl  audit partner arthur andersen llpunited states former website wwwwestpharmacom corporate information address  gordon drive po box  lionville pa  united states phone  fax  web url wwwwestpharmacom from the web personal information education rutgers the state university of new jersey bachelors degree economics rutgers the state university of new jersey mba awards  publications certificates certified public accountant cpa memberships board memberships zynerba pharmaceuticals inc board member present nupathe inc board member  synvista therapeutics inc board member  show more other memberships cancer care of new jersey trustee sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data nupathe appoints william j federici to its board of directorshomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoreyahoosearchsearchskip to navigationskip to main contentskip to related contentnupathe appoints william j federici to its board of directorsmarketwirejanuary  reblogsharetweetshareconshohocken pamarketwire    nupathe inc nasdaqpath  news a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system including neurological and psychiatric disorders today announced that william j federici vice president and chief financial officer of west pharmaceutical services inc has been appointed to the nupathe board of directors mr federici will also serve on the audit committeewe are delighted to add bill to our board of directors said jane hollingsworth chief executive officer of nupathe in addition to his significant financial and accounting acumen bills experience as a chief financial officer of a global manufacturer of components and delivery systems for the pharmaceuticals healthcare and consumer products industries will be invaluable to the company especially as we prepare for a robust commercial launch of zelrixmr federici joined west pharmaceutical services in  with more than  years experience in public accounting for the pharmaceutical industry prior to joining west mr federici served as practice leader for the pharmaceuticals industry in the americas and engagement partner for several pharmaceutical companies at kpmg llpmr federici holds a ba in economics and an mba in professional accounting from rutgers university and is a certified public accountant mr federici is also an advisory board member of the rutgers university school of business and a member of the board of trustees at cancer care of new jerseyabout nupathenupathe inc wwwnupathecom is a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system including neurological and psychiatric disorders nupathes most advanced product candidate zelrix is a singleuse transdermal sumatriptan patch being developed for the treatment of acute migraine in addition to zelrix nupathe has two proprietary product candidates in preclinical development np for the continuous symptomatic treatment of parkinsons disease and np for the longterm treatment of schizophrenia and bipolar disorderreblogsharetweetsharepopular in the communityliev schreiber took his son to comiccon dressed as harley quinn reactionseight bodies found in overheated truck in a walmart in texas reactionsemily ratajkowski poses poolside in perplexing cutout top reactionsyoung reds fan gets angry with dee gordon kicks him in the shin reactionsvenezuela’s symphony of protests reactionstexas tractortrailer incident called horrific case of human smuggling reactionsluis fonsi on justin biebers spanish despacito hitting no  reactionstrump suggests republicans should ‘protect their president’ reactionsreport kyrie irving believes lebron james leaked trade request reactionshorrific humansmuggling incident in texas not an isolated event officials say reactionsamazing images of light under desert archways reactionsmixed messages from white house on talk of pardons reactionshistoric pearl river mart reopens to bring crosscultural joy to nyc reactionsthis man became severely disfigured after a barbershop mishap — complete strangers helped change his life reactionsjennifer lopez continues to show shes still got it and probably always will reactionsfollow these simple rules and live  years longer reactionskellyanne conway explains what she meant by ‘alternative facts’clifford carraher i couldnt bring myself to watch her explain what she meant by alternatives facts with alternative factsjoin the conversation  k william j federici  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in william j federici senior vice president and chief financial officer at west pharmaceutical services inc view full profile are you william j federici claim your profile   sign up for equilar atlas and view william j federicis full profile with equilar atlas you can identify corporate executives in william j federicis network and community follow changes in william j federicis employment and moneyinmotion connect with william j federici through your network of contacts william j federicis executive work history current senior vice president and chief financial officer west pharmaceutical services inc board member zynerba pharmaceuticals inc past to view william j federicis complete executive work history sign up now age      william j federicis biography william j federici has served as a member of our board since august  mr federici has served as senior vice president and chief financial officer of west pharmaceutical services inc a publicly traded global pharmaceutical technology company since august  he served as a member of the board of directors and chairman of the audit committee at nupathe from january  until february  from june  until august  he was national industry director for pharmaceuticals of kpmg llp and prior thereto he was an audit partner with arthur andersen llp mr federici holds a ba in economics and an mba in professional accoun  read more william j federici has served as a member of our board since august  mr federici has served as senior vice president and chief financial officer of west pharmaceutical services inc a publicly traded global pharmaceutical technology company since august  he served as a member of the board of directors and chairman of the audit committee at nupathe from january  until february  from june  until august  he was national industry director for pharmaceuticals of kpmg llp and prior thereto he was an audit partner with arthur andersen llp mr federici holds a ba in economics and an mba in professional accounting from rutgers university and is a certified public accountant with his leadership experience in the global pharmaceutical and accounting industries mr federici brings valuable expertise in financial and auditrelated matters to our board source zynerba pharmaceuticals inc on    sign up for equilar atlas and view william j federicis full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like william j federici more specifically youll be able to identify corporate executives in william j federicis network and community follow changes in william j federicis employment and moneyinmotion connect with william j federici through your network of conections view full profile   search for over  executive profiles bio example william j federici william j federicis connections  sign up now to view william j federicis  connections » anthony welters board member c r bard inc james a datin former executive vice president and managing director life sciences safeguard scientifics inc brian j sisko chief operating officer executive vice president and managing director safeguard scientifics inc donald e morel board member catalent inc john h weiland dir president and chief operating officer c r bard inc mark a buthman board member west pharmaceutical services inc myla p laigoldman board member west pharmaceutical services inc jenne k britell board member crown holdings inc daniel l kisner board member conatus pharmaceuticals inc annette f favorite senior vice president and chief human resources officer west pharmaceutical services inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla daniel a dematteo executive chairman gamestop corp david j oconnor president and ceo the madison square garden company × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   form  zynerba pharmaceuticals for jun  filed by federici william j research stocks news story skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  news  events  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print format change text size default text sizea larger text sizea largest text sizea form  zynerba pharmaceuticals for jun  filed by federici william j by k wizard—  pm et  httparchivefastedgarcomafcoqojcxmppdbd filed on june   more zyne news briefzynerba pharma achieves target enrollment in exploratory phase  trial of zyn in fragile x syndrome reuters   am et  zynerba pharmaceuticals achieves target enrollment in exploratory phase  trial of zyn in fragile x syndrome globenewswire   am et  legal cannabis and cbd markets are projected to grow pr newswire   am et  copyright – fmr llc  all rights reserved  terms of use privacy security site map  stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top bofi log in for events hafc an earn epam sn log in for events chkp lho fit gts find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  pm et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  zyne stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventszyne zynerba pharmaceuticals inc    as of pm et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade option chain price history download to csv file download to excel file log in for more news expand all collapse all sales of legal cannabis products are expected to accelerate pr newswire –  am et  new york july   according to a research report by new frontier data medical cannabis sales are forecast to grow to  billion in  and accounting for  of total cannabis sales cannabis stocks significantly outperformed major indexes in  fueled by speculative investment based on anticipated expansion of new legal markets legal cannabis and cbdbased products projected to gain popularity pr newswire –  am et  new york june   according to a recent report by new frontier data the viridian cannabis stock index gained  in  or outperforming such mainstream indexes as the russell  the dow jones industrial average the sp  and the nasdaq composite a major portion of the legal cannabis market is the hemp and cbd market zynerba pharmaceuticals added to the russell ® index globenewswire –  am et  zynerba pharmaceuticals inc zyne a clinicalstage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid treatments today announced that it has been added to the russell ® index as part of the ftses annual reconstitution of its family of us indexes briefzynerba pharmaceuticals initiates zyn phase  clinical program reuters –  am et  zynerba pharmaceuticals inc zyne  zynerba pharmaceuticals zyne initiates zyn phase  clinical program  zynerba pharmaceuticals inc zyne  study includes single rising dose and multiple rising dose evaluations for zyn zynerba pharmaceuticals initiates zyn phase  clinical program globenewswire –  am et  phase  results will inform potential phase  studies in patients with fibromyalgia and neuropathic pain planned to start in h study includes single rising dose and multiple rising dose evaluations zynerba pharmaceuticals inc zyne a clinicalstage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid treatments today announc consumers spending on legal cannabis products projected to grow pr newswire –  am et  new york june   according to a report by new frontier data medical cannabis sales in  are forecast to grow to  billion which is  of total cannabis sales data shows that cannabis stocks significantly outperformed major indexes in  which is a result of speculative investment based on anticipated expansion of new legal markets briefzynerba pharma achieves target enrollment in exploratory phase  trial of zyn in fragile x syndrome reuters –  am et  zynerba pharmaceuticals inc zyne  zynerba pharmaceuticals zyne achieves target enrollment in exploratory phase  trial of zyn in fragile x syndrome source text for eikon further company coverage zynerba pharmaceuticals achieves target enrollment in exploratory phase  trial of zyn in fragile x syndrome globenewswire –  am et  zynerba pharmaceuticals inc zyne a clinicalstage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid treatments today announced that it has met its enrollment target of  patients in its phase  fabc clinical trial evaluating zyn cannabidiol gel in children with fragile x syndrome legal cannabis and cbd markets are projected to grow pr newswire –  am et  new york june   according to a research report published by arcview market research the growth of the legal cannabis market is projected to reaccelerate beginning in  a major component of the legal cannabis industry is the cbd market zynerba pharmaceuticals to present at the jefferies  global healthcare conference globenewswire –  am et  zynerba pharmaceuticals inc zyne a clinicalstage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid treatments today announced that zynerbas chief financial officer jim fickenscher will present a company overview at the jefferies  global healthcare conference on thursday june  at  pm et at the grand hyatt in ne how these generic drugs stocks are faring  myos rens technology akari therapeutics flexion therapeutics and zynerba pharma pr newswire –  am et  new york may   on thursday may   the nasdaq composite the dow jones industrial average and the sp  edged higher at the closing bell httpstockcallerscomregistration legal cannabis and cbd markets grow in the united states pr newswire –  am et  new york may   according to a research by new frontier data the legal cannabis market was worth an estimated  billion in  one major component of the legal cannabis industry is the cbd market briefzynerba pharmaceuticals reports q loss per share  reuters –  am et  zynerba pharmaceuticals inc zyne  zynerba pharmaceuticals zyne reports first quarter  financial results and operational highlights zynerba pharmaceuticals reports first quarter  financial results and operational highlights globenewswire –  am et  zynerba pharmaceuticals inc zyne a clinicalstage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid treatments today reported financial results for the first quarter ended march   and provided an overview of recent operational highlights the creation of jobs in the legal cannabis market pr newswire –  am et  new york may   according to a research by arcview market research retail sales taxes in statesanctioned cannabis markets totaled more than  million in  in colorado washington oregon and  million since adultuse sales began in  zynerba pharmaceuticals reports fourth quarter and year end  financial results and operational highlights globenewswire –  am et  zynerba pharmaceuticals inc zyne a clinicalstage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid treatments today reported financial results for the fourth quarter and year ended december   and provided an overview of recent operational highlights zynerba pharmaceuticals to report fourth quarter and fullyear  financial and operating results on march   globenewswire –  am et  zynerba pharmaceuticals inc zyne a clinicalstage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments today announced that the company will report its fourth quarter and fullyear  financial results and recent operating progress on monday march   zynerba pharmaceuticals announces completion of enrollment for zyn in two phase  clinical trials for epilepsy and osteoarthritis globenewswire –  am et  zynerba pharmaceuticals inc zyne a clinicalstage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments today announced that it has completed enrollment in the phase  star  clinical trial evaluating zyn cannabidiol gel in adult epilepsy patients with refractory focal seizures zynerba pharmaceuticals to participate in upcoming investor conferences globenewswire –  am et  zynerba pharmaceuticals inc zyne a clinicalstage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments today announced that armando anido chairman and chief executive officer will present at upcoming investor conferences in march including to listen to a webcast of the presentations live please visit the investor relations  zynerba pharmaceuticals announces full exercise of underwriters option to purchase additional shares globenewswire –  am et  zynerba pharmaceuticals zyne inc  a clinicalstage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments today announced that the underwriters of its previously announced public offering of  million shares of its common stock have exercised in full their option to purchase an additional  shares of common stock at the pu page page   next  todays and upcoming events aug  zyne to announce q earnings before market unconfirmed past events last  days jun  shareholders meeting data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe william federici vice president and chief financial officer west pharmaceutical services inc  spoke login register add company add person add topic login or home  people  william federici advanced search faq javascript is disabled bio edit william federici william federici vice president and chief financial officer west pharmaceutical services inc exton pa find other people named william federici general info manufacturer of fabricated rubber products add tags— eg finance businessbusiness william j federici vice president and chief financial officer not who youre looking for find other william federicis on spoke contact telephone email background report public records powered by digital info wwwwestpharmacom na na na na na na resume edit career west pharmaceutical services inc vice president and chief financial officer education edit add a degree— eg bachelors in business administration blogs by industry voices there are currently no blogs by industry voices achievements and recognition edit add an achievement andor recognition— eg man of the year forbes  notable links edit the links below are powered by bing search results click edit to customize videos edit add a videofrom youtube or vimeo executives  featured people at west pharmaceutical services inc robert hargesheimer president richard luzzi vice president human resources anthony welters chairman michael anderson vice president and treasurer steven ellers presidentcoo john gailey vice president robert keating president europe and asia pacific pharmaceutical systems division donald morel chief executive officer created on jun   by spoke   edited on jun   by spoke   page completion  career websiteblog industry add  notable links add  achievements add a summary add a video add education add a photo add a social network view more view less share this page add page add company add person add topic copy this code to embed a widget div idspokerootdiv scriptfunctiond s id document script spokewidgetjsscript div classspokewidget datahostwwwspokecom datatypeperson dataidececd datawidth dataheight datascrollno dataframebordernonediv div stylefontsize pta hrefhttpwwwspokecompeoplewilliamfedericiececdwilliam federicia widget provided by a hrefhttpwwwspokecomspokeadiv public records our partner can help you find public records for william more on some of spokes content providers become a spoke content provider learn more william federici  west pharmaceutical services inc  zoominfocom william j federici  bridgewater nj  intelius sign in we found william j federici in bridgewater nj william j federici intelius found that william j federici is a female between  and  years old from bridgewater nj we have connected them to  addresses  phones and  relatives or associates get report now age william j federici is in her s william has lived in bridgewater nj belle mead nj devon pa williams relatives susan federici thomas federici kevin federici nicholas federici william j federici zodiac signcancer genderfemale professional status board member at zynerba pharmaceuticals inc get report now want to know more about william get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about william or use our people search engine to find others get background check on william j federici get a criminal check on william j federici get a public record report on william j federici get a people search report on william j federici william j federicis contact information known cities lived in find out where william j federici has lived as well as william j federicis phone numbers and email addresses william j federici has lived in  states new jersey address for william j federici  r r bridgewater nj has lived in bridgewater nj belle mead nj get full address report phone numbers associated with william j federici    bridgewater nj    new town pa    hillsborough nj get full phone report email addresses associated with william j federici hcom wmcom get email report william j federicis professional information information regarding william j federicis professional history find out previous places william j federici has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act william j federici has worked at  place company zynerba pharmaceuticals inc title board member william j federicis experience title board member company zynerba pharmaceuticals inc job details at zynerba pharmaceuticals we are dedicated to developing innovative transdermal cannabinoid treatments for patients with high unmet medical needs using modern drug delivery technology and appropriate regulatory pathways our mission is to improve the lives of patients battling severe health conditions including fibromyalgia neuropathic pain breakthrough cancer pain epilepsy and rheumatoid arthritis through these novel pharmaceutical treatments our development pipeline is based on our proprietary technologies that are designed to deliver sustained consistent and controlled levels of therapeutic cannabinoids additional professional information on william j federici see william j federicis linkedin profile william j federicis social network and potential email matches find out potential social network profiles and potential email usernamed for william j federici william j federicis known social networks and potential email matches find all of william j federicis social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches william federici username matches williamfederici federiciwilliam williamfederici federiciwilliam williamfederici federiciwilliam williamfederici federiciwilliam wfederici popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches w federici intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here